Oragenics Earnings Estimates, EPS & Revenue | AMEX:OGEN

Comments

Oragenics Inc Earnings Estimates

OGENAMEX

Trade with Public

$0.8885

0.02733.17%

At close: Mar 5, 4:00 PM EST

$0.8799

-0.0086-0.97%

After Hours: 6:45 PM EST

Overview NewsEarningsInsider Trades Short Interest Stock Report

Oragenics Earnings Estimates, EPS & Revenue | AMEX:OGEN

Oragenics (OGEN) is scheduled to report Q4 earnings on March 17, 2026.

Oragenics has beaten EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, Oragenics has averaged an EPS surprise of 0.71% and a revenue surprise of 0.00%.

Earnings Date

Nov 7

EPS

$-1.960

Quarterly Revenue

$0.00

Annual Revenue
(as of Sep 30)

–

Oragenics Earnings History

Analyze the earnings history of Oragenics using advanced sorting and filters.

Oragenics (OGEN) Earnings Per Share

The chart below shows Oragenics's reported EPS compared to analyst estimates over recent quarters.

Oragenics (OGEN) Revenue

The chart below shows Oragenics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Oragenics (AMEX:OGEN) reporting earnings?

Oragenics (OGEN) is scheduled to report earnings on May 8, 2026. The last reported earnings were for reported on November 7, 2025 for Q3.

What were the latest earnings per share (EPS) for Oragenics (AMEX:OGEN)?

The Actual EPS was $-1.96, which missed the estimate of $0.00.

What were Oragenics’s (AMEX:OGEN) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Dermata Therapeutics Inc

NASDAQ:DRMA

$1.18

-2.49%

Acurx Pharmaceuticals Inc

AquaBounty Technologies Inc

NASDAQ:AQB

$0.95

2.15%

Indaptus Therapeutics Inc

Ensysce Biosciences Inc

NASDAQ:ENSC

$0.52

-2.80%

Oragenics Earnings Estimates, EPS & Revenue | AMEX:OGEN

Oragenics (OGEN) is scheduled to report Q4 earnings on March 17, 2026.

Oragenics has beaten EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, Oragenics has averaged an EPS surprise of 0.71% and a revenue surprise of 0.00%.

Earnings Date

Nov 7

EPS

$-1.960

Quarterly Revenue

$0.00

Annual Revenue
(as of Sep 30)

–